A UK epidemic of testosterone prescribing, 2001-2010

Clinical Endocrinology

Volumn 79, Issue 4, 2013, Pages 564-570

  Gan, Earn H ^a,b   Pattman, Stewart ^b   H S Pearce, Simon ^a   Quinton, Richard ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE; TOSTRAN; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; DRUG COST; HUMAN; HYPOGONADISM; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM;

ADMINISTRATION, CUTANEOUS; DRUG COSTS; DRUG PRESCRIPTIONS; ENGLAND; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; REGISTRIES; SCOTLAND; STATE MEDICINE; TESTOSTERONE; WALES;

EID: 84883507909     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12178     Document Type: Review

References (43)

1. Berthold, A., (1849) Transplantation der Hoden. Arch Anat Physiol Wissensch, 42.
2. Benito, M., Gomberg, B., Wehrli, F.W., et al,. (2003) Deterioration of trabecular architecture in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 88, 1497-1502.
3. Wu, F.C.W., Tajar, A., Pye, S.R., et al,. (2008) Hypothalamic-pituitary- testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study. Journal of Clinical Endocrinology and Metabolism, 93, 2737-2745.
4. Aakvaag, A., Sand, T., Opstad, P.K., et al,. (1978) Hormonal changes in serum in young men during prolonged physical strain. European journal of applied physiology and occupational physiology 39, 283-91.
5. Caronia, L.M., Dwyer, A.A., Hayden, D., et al,. (2012) Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism. Clinical Endocrinology, 78, 291-296.
6. Madersbacher, S., Grunberger, T., &, Maier, U., (1994) Andrological status before and after liver transplantation. Journal of Urology, 15, 1251-1254.
7. Reddy, R.G., Aung, T., Karavitaki, N., et al,. (2010) Opioid induced hypogonadism. BMJ, 341, 605-606.
8. Montejo, A.L., Llorca, G., Izquierdo, J.A., et al,. (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Journal of Clinical Psychiatry, 62, 10-21.
9. Konarzewska, B., Wołczyński, S., Szulc, A., et al,. (2009) Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology, 34, 129-139.
10. Nudell, D.M., Monoski, M.M., &, Lipshultz, L.I., (2002) Common medications and drugs: how they affect male fertility. Urologic Clinics of North America, 29, 965-973.
11. Pirola, I., Cappelli, C., Delbarba, A., et al,. (2010) Anabolic steroids purchased on Internet as a cause of prolonged hypogonadotropic hypogonadism. Fertil Sterol, 94, 2331e1-2331.
12. Muthusami, K.R., &, Chinnaswamy, P., (2005) Effect of chronic alcoholism on male fertility hormones and semen quality. Fertility and Sterility, 84, 919-924.
13. Hembree, W.C., Nahas, G.G., Zeidenberg, P., et al,. (1979) Changes in human spermatozoa associated with high dose marihuana smoking. In:, G.G. Nahas, W.D.M. Paton, eds. Marijuana Biological Effects: Analyses, Metabolism, Cellular Responses, Reproduction and Brain. Pergamon Press, New York, NY, 429-439.
14. Sridhar, S., Walia, R., Sachdeva, N., et al,. (2012) Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double blind placebo-controlled study. Clinical endocrinology, 78, 454-459.
15. Synder, P.J., Peachey, H., Hannoush, P., et al,. (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. Journal of Clinical Endocrinology and Metabolism, 84, 2647-2653.
16. Emmelot-vonk, M.H., Verhaar, H.J., Nakhai Pour, H.R., et al,. (2008) Effect of testosterone supplementation on functional mobility, cognition and other parameters in older men: a randomised controlled trial. JAMA, 299, 39-52.
17. Srinivas-Shankar, U., Roberts, S.A., Connolly, M.J., et al,. (2010) Effects of testosterone on muscle strength, physical function, body composition and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. The Journal of clinical endocrinology and metabolism, 95, 639-650.
18. Bakhshi, V., Elliott, M., Gentili, A., et al,. (2008) Testosterone improves rehabilitation outcomes in ill older men. Journal of the American Geriatrics Society, 48, 550-553.
19. Nigro, N., &, Christ-Crain, M., (2012) Testosterone treatment in the aging male: myth or reality? Swiss medical weekly, 142, w13539.
20. National Research Council (2004) Testosterone and Aging: Clinical Research Directions. The National Academies Press, Washington, DC.
21. Handelsman, D.J., (2012) Pharmacoepidemiology of testosterone prescribing in Australia, 1992-2010. The Medical journal of Australia, 196, 642-645.
22. Morris, J.K., Alberman, E., Scott, C., et al,. (2008) Is the prevalence of Klinefelter syndrome increasing? European Journal of Human Genetics, 16, 163-70.
23. Herlihy, A.S., Halliday, J.L., Cock, M.L., et al,. (2011) The prevalence and diagnosis rates of Klinefelter syndrome: an Australian comparison. Medical Journal of Australia, 194, 24-28.
24. Bojesen, A., &, Gravholt, C.H., (2007) Klinefelter syndrome in clinical practise. Nature Clinical Practice Urology, 4, 192-204.
25. Basaria, S., Coviello, A.D., Travison, T.G., et al,. (2010) Adverse events associated with testosterone administration. The New England journal of medicine, 363, 109-122.
26. Wu, F.C.W., Tajar, A., Beynon, J.M., et al,. (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. The New England journal of medicine, 363, 123-135.
27. Pettypiece, S., (2012) Are testosterone drugs the next Viagra? Bloomberg business week. [online] Available at: http://www.businessweek.com/articles/2012- 05-10/are-testosterone-drugs-the-next-viagra [Accessed 26 November 2012].
28. Powledge, T., (2012) Stemming the rush to male HRT. The Scientist. [online] Available at: < http://www.the-scientist.com/?articles.view/ articleNo/15375/title/Stemming-the-Rush-to-Male-HRT/ > [Accessed 26 November 2012].
29. Perrone, M., (2012) Testosterone marketing frenzy draws skepticism. The Associated Press. [online] Available at: http://vitals.nbcnews.com/-news/2012/ 09/09/13761777-testosterone-marketing-frenzy-draws-skepticism?lite [Accessed 27 November 2012].
30. Ferring Pharmaceuticals. 2011 [online] Available at: < http://www.menshealthmatters.org> [Accessed 26 November 2012]
31. Bayer Pharma, A.G., (2010) [online] Available at: http://www.nebido.com/ en/patients/index.php [Accessed 26 November 2012]
32. Bayer Schering Pharma. (2009) 'Hypogonadism explained for men with testosterone deficiency. [Online] Available at: http://www.nebido.com/./ Hypogonadism-Explained-Booklet-Mar09.pdf [Accessed September 2012]
33. Abbott Laboratories. (2010) [online] Available at: http://www.androgel. com [Accessed 26 November 2012].
34. Feldman, H.A., Longcope, C., Derby, C.A., et al,. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism, 87, 589-598.
35. Araujo, A.B., Shi, Z., Martin, S.M., et al,. (2012) Longitudinal changes in testosterone over 5 Years in community-dwelling men. ENDO 2012, Abstract Mon-34.
36. Frost, M., Wraae, L., Nielsen, T., et al,. (2012) Similar reference intervals for total testosterone in healthy young and elderly men. Results from the Odense Androgen Study. Clinical Endocrinology, 78, 743-751.
37. Tajar, A., Huhtaniemi, I.T., O'Neill, T.W., et al,. (2012) Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). Journal of Clinical Endocrinology and Metabolism, 97, 1508-1516.
38. Calof, O.M., Singh, A.B., Lee, M.L., et al,. (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 60, 1451-1457.
39. van den Beld, A.W., Visser, T.J., Feelders, R.A., et al,. (2005) Thyroid hormone concentration, disease, physical function and mortality in elderly men. The Journal of clinical endocrinology and metabolism, 90, 6403-6409.
40. Bhasin, S., Cunningham, G.R., Hayes, F.J., et al,. (2010) Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95, 2536-2559.
41. Dandona, P., &, Rosenberh, M.T., (2010) A practical guide to male hypogonadism in the primary care setting. International journal of clinical practice, 64, 682-696.
42. Wang, C., Nieschlag, E., Swerdloff, R., et al,. (2008) Consensus statement: investigation, treatment and monitoring of late-onset hypogonadism in males (ISA, ISSAM, EAU, EAA and ASA recommendations). European Journal of Endocrinology, 159, 507-514.
43. Society for Endocrinology's Clinical Committee. (2012) Society of Endocrinology Position Statement on male hypogonadism and ageing. [online] Available at: www.endocrinology.org/./12-10-HypogonadismAndAgeing.pdf [Accessed 26 November 2012]